Results 221 to 230 of about 226,280 (311)

Impact of Integrated Control Interventions on Sandfly Populations in Human and Canine Visceral Leishmaniasis Control in Araçatuba, State of São Paulo, Brazil. [PDF]

Insects
Luz-Requena KAM, Suto TMT, Rangel O, Stringheta RCLL, Santos-Doni TR, Rodas LAC, Bresciani KDS.   +6 more
europepmc   +1 more source

Modeling the seasonal and climate-dependent dynamics of visceral leishmaniasis in Brazil: Implications for transmission and Control. [PDF]

Infect Dis Model
Adams QH, Hamer DH, Hutyra LR, Wellenius GA, Shioda K.   +4 more
europepmc   +1 more source

Visceral leishmaniasis co-infection and AIDS in Brazil, 2001-2010

, 2012
Marcia Lucia de Oliveira Gomes
openalex   +1 more source

Dyserythropoiesis in visceral leishmaniasis [PDF]

American Journal of Hematology, 2010
openaire   +2 more sources

The story of elimination of visceral leishmaniasis (kala-azar) in India-Challenges towards sustainment. [PDF]

PLoS Negl Trop Dis
Sundar S.
europepmc   +1 more source

Recent developments and future prospects in the treatment of visceral leishmaniasis

Therapeutic Advances in Infectious Disease, 2016
S. Sundar, Anup Singh
semanticscholar   +1 more source

Evaluating the contribution of weather variables to machine learning forecasts of visceral leishmaniasis in Brazil. [PDF]

Environ Res Health
Adams QH, Milando CW, Shioda K, Werneck GL, Rodríguez A, Hamer DH, Wellenius GA.   +6 more
europepmc   +1 more source

Design of a novel multi epitope antigen for diagnosis of visceral leishmaniasis using an immunoinformatics approach. [PDF]

Sci Rep
Baneshi M, Sadeghi M, Hashemi S, Alcedo C, Muro A, Manzano-Román R, Savardashtaki A, Rashidi S.   +7 more
europepmc   +1 more source

Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression

, 2017
Audrie A. Medina-Colorado, E. Yaneth Osorio, Ómar A. Saldarriaga, Bruno L. Travi, Fanping Kong, Heidi Spratt, Lynn Soong, Peter C. Melby   +7 more
openalex   +2 more sources

Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral Leishmaniasis. [PDF]

Pathogens
Jesus MM, Lage DP, Pimenta BL, Moreira GJL, Pereira IAG, Câmara RSB, Silva AL, Tavares GSV, Falcão KOM, Dias SSG, Abrão DM, Rodrigues MM, Oliveira-da-Silva JA, Giusta MS, Chávez-Fumagalli MA, Roatt BM, Galdino AS, Christodoulides M, Freitas CS, Coelho EAF.   +19 more
europepmc   +1 more source